Your browser doesn't support javascript.
loading
A GABBR2 gene variant modifies pathophysiology in Huntington's disease.
Philpott, April L; Fitzgerald, Paul B; Bailey, Neil W; Churchyard, Andrew; Georgiou-Karistianis, Nellie; Cummins, Tarrant D R.
Afiliação
  • Philpott AL; School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton, VIC 3800, Australia.
  • Fitzgerald PB; Monash Alfred Psychiatry Research Centre, Central Clinical School, Monash University and the Alfred, Melbourne, VIC 3004, Australia.
  • Bailey NW; Monash Alfred Psychiatry Research Centre, Central Clinical School, Monash University and the Alfred, Melbourne, VIC 3004, Australia.
  • Churchyard A; Department of Neurology, Monash Medical Centre, Clayton, VIC 3800, Australia.
  • Georgiou-Karistianis N; School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton, VIC 3800, Australia. Electronic address: nellie.georgiou-karistianis@monash.edu.
  • Cummins TD; School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton, VIC 3800, Australia.
Neurosci Lett ; 620: 8-13, 2016 05 04.
Article em En | MEDLINE | ID: mdl-27033668

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Huntington / Receptores de GABA-B Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Huntington / Receptores de GABA-B Idioma: En Ano de publicação: 2016 Tipo de documento: Article